Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells. (Q49334989)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 November 2017

Language	Label	Description	Also known as
English	Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.	scientific article published on 6 November 2017

Statements

scholarly article

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells. (English)

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jing Chen

1

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Hulai Wei

2

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Jie Cheng

3

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Bei Xie

4

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Bei Wang

5

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Juan Yi

6

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Baoying Tian

7

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Zhuan Liu

8

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Feifei Wang

9

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Zhewen Zhang

10

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

publication date

6 November 2017

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Oncology Letters

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

15

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

1

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

1255-1262

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Expression of P-gp in acute myeloid leukemia and the reversal function of As2O3 on drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Selective elimination of leukemia stem cells: hitting a moving target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Acute myelogenous leukemia stem cells: from Bench to Bedside.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Arsenic trioxide inhibits p-glycoprotein expression in multidrug-resistant human leukemia cells that overexpress the MDR1 gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

22 May 2018

Overcoming treatment resistance in acute promyelocytic leukemia and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

14 August 2018

PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

14 August 2018

Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

14 August 2018

Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

14 August 2018

Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

14 August 2018

The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5768105

14 August 2018

Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29399180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MDR1 modulates apoptosis in CD34+ leukemic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/29399180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-Cadherin and Tie2 positive CD34⁺CD38⁻CD123⁺ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/29399180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to arsenic therapy in acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29399180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OL.2017.7353

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5768105

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49334989&oldid=1477681204"